Literature DB >> 16229856

Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.

K A Phillips1, W Menard, M E Pagano, C Fay, R L Stout.   

Abstract

DSM-IV's classification of body dysmorphic disorder (BDD) is controversial. Whereas BDD is classified as a somatoform disorder, its delusional variant is classified as a psychotic disorder. However, the relationship between these BDD variants has received little investigation. In this study, we compared BDD's delusional and nondelusional variants in 191 subjects using reliable and valid measures that assessed a variety of domains. Subjects with delusional BDD were similar to those with nondelusional BDD in terms of most variables, including most demographic features, BDD characteristics, most measures of functional impairment and quality of life, comorbidity, and family history. Delusional and nondelusional subjects also had a similar probability of remitting from BDD over 1 year of prospective follow-up. However, delusional subjects had significantly lower educational attainment, were more likely to have attempted suicide, had poorer social functioning on several measures, were more likely to have drug abuse or dependence, were less likely to currently be receiving mental health treatment, and had more severe BDD symptoms. However, when controlling for BDD symptom severity, the two groups differed only in terms of educational attainment. These findings indicate that BDD's delusional and nondelusional forms have many more similarities than differences, although on several measures delusional subjects evidenced greater morbidity, which appeared accounted for by their more severe BDD symptoms. Thus, these findings offer some support for the hypothesis that these two BDD variants may constitute the same disorder. Additional studies are needed to examine this issue, which may have relevance for other disorders with both delusional and nondelusional variants in DSM.

Entities:  

Mesh:

Year:  2005        PMID: 16229856      PMCID: PMC2809249          DOI: 10.1016/j.jpsychires.2005.08.005

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  35 in total

1.  A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive Compulsive Scale.

Authors:  K A Phillips; E Hollander; S A Rasmussen; B R Aronowitz; C DeCaria; W K Goodman
Journal:  Psychopharmacol Bull       Date:  1997

2.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

3.  Suicidal ideation and suicide attempts in body dysmorphic disorder.

Authors:  Katharine A Phillips; Meredith E Coles; William Menard; Shirley Yen; Christina Fay; Risa B Weisberg
Journal:  J Clin Psychiatry       Date:  2005-06       Impact factor: 4.384

4.  Perceived stress in body dysmorphic disorder.

Authors:  L M DeMarco; L C Li; K A Phillips; S L McElroy
Journal:  J Nerv Ment Dis       Date:  1998-11       Impact factor: 2.254

Review 5.  Identification of suicide risk factors using epidemiologic studies.

Authors:  E K Mościcki
Journal:  Psychiatr Clin North Am       Date:  1997-09

6.  Candidate neuroanatomic substrates of psychosis in old-aged depression.

Authors:  D K Kim; B L Kim; S E Sohn; S W Lim; D G Na; C H Paik; K R Krishnan; B J Carroll
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1999-07       Impact factor: 5.067

7.  The Brown Assessment of Beliefs Scale: reliability and validity.

Authors:  J L Eisen; K A Phillips; L Baer; D A Beer; K D Atala; S A Rasmussen
Journal:  Am J Psychiatry       Date:  1998-01       Impact factor: 18.112

8.  Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips
Journal:  Am J Psychiatry       Date:  2005-02       Impact factor: 18.112

9.  The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment.

Authors:  A C Leon; D A Solomon; T I Mueller; C L Turvey; J Endicott; M B Keller
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

10.  Depression, anxiety, anger, and somatic symptoms in patients with body dysmorphic disorder.

Authors:  Katharine A Phillips; Jason M Siniscalchi; Susan L McElroy
Journal:  Psychiatr Q       Date:  2004
View more
  41 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

2.  Treatment with risperidone and venlafaxine of a patient with double-coded diagnosis of body dysmorphic disorder and delusional disorder somatic type.

Authors:  P Goulia; Ch Mantas; Ioannis D Bassukas; Th Hyphantis
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

Review 3.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

4.  An Empirical Model of Body Image Disturbance Using Behavioral Principles found in Functional Analytic Psychotherapy and Acceptance and Commitment Therapy.

Authors:  Glenn M Callaghan; Julissa A Duenas; Sarah E Nadeau; Sabrina M Darrow; Jessica Van der Merwe; Jennifer Misko
Journal:  Int J Behav Consult Ther       Date:  2012-04-01

Review 5.  Visual processing in anorexia nervosa and body dysmorphic disorder: similarities, differences, and future research directions.

Authors:  Sarah K Madsen; Cara Bohon; Jamie D Feusner
Journal:  J Psychiatr Res       Date:  2013-06-27       Impact factor: 4.791

6.  Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ashley S Hart; William Menard; Jane L Eisen
Journal:  J Nerv Ment Dis       Date:  2013-07       Impact factor: 2.254

7.  Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.

Authors:  Katharine A Phillips; Aparna Keshaviah; Darin D Dougherty; Robert L Stout; William Menard; Sabine Wilhelm
Journal:  Am J Psychiatry       Date:  2016-04-08       Impact factor: 18.112

8.  Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.

Authors:  Katharine A Phillips; Robert L Stout
Journal:  J Psychiatr Res       Date:  2005-11-23       Impact factor: 4.791

9.  High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.

Authors:  W Louis Cleveland; Robert L DeLaPaz; Rashid A Fawwaz; Roger S Challop
Journal:  Neural Plast       Date:  2010-02-18       Impact factor: 3.599

10.  Abnormal brain network organization in body dysmorphic disorder.

Authors:  Donatello Arienzo; Alex Leow; Jesse A Brown; Liang Zhan; Johnson Gadelkarim; Sarit Hovav; Jamie D Feusner
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.